Adalimumab efficacy and safety in patients with moderate to severe chronic plaque psoriasis: preliminary findings from a 12-week dose-ranging trial
- 31 March 2004
- journal article
- abstracts
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 50 (3), P1
- https://doi.org/10.1016/j.jaad.2003.10.008